AstraZeneca – AstraZeneca : Lokelma label replace authorized in China for sufferers with hyperkalaemia on power haemodialysis; Label replace is predicated on information from Part IIIb DIALIZE trial
AstraZeneca - AstraZeneca : Lokelma label replace authorized in China for sufferers with hyperkalaemia on power haemodialysis; Label replace is ...
